Lauri Carlile on LinkedIn: Welcome! You are invited to join a meeting: Pediatric Cell and Gene… (2024)

If you'll be at DIA in June, I hope you'll join CluePoints and Advarra for an evening of excitement, celebration, and valuable networking with our peers in the healthcare industry, regulatory government, academics, patients, and more! Get the info and sign up: https://cvent.me/AN7Be1#clinicalresearch #clinicaltrials #dia2024

15

Need a refresher on IRB noncompliance reporting? Check out our recently revised blog:

8

Race & ethnicity impact how individuals respond to medical products. FDA's new draft guidance recommends standardized data collection and reporting to ensure equitable healthcare outcomes. Your input matters!

20

How do we as a research community balance the need for greater inclusivity with protecting vulnerable participants? Join our 4/11 webinar for a fascinating discussion by Luke Gelinas:

15

Until 2024, FDA hadn't updated its DMC guidance in almost 20 years. Find out what the agency changed (and what it didn't) in our blog #DMC #clinicaltrials #regulatory

31

Just because an sIRB is reviewing the study doesn’t mean the local IRB has nothing to do. Read our blog for more on HRPP roles:

24

1 Comment

How do we as a research community balance the need for greater inclusivity with protecting vulnerable participants? Join our 4/2 webinar for a fascinating discussion by Luke Gelinas:

21

Advarra is more than an IRB – we’re your one-stop shop for DMC, EAC, CEC, and IBC. Other providers can’t match our expert network and integrated solutions.

28

I know organizations like yours are looking for ways to speed up trials while keeping sites on track. At Advarra, we believe better site performance and compliance start with you – the study team. Don’t miss our upcoming webinar on February 22, where we will review industry trends and real study use cases on how to improve operational outcomes by focusing on the research experience.

27